Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 1
2007 4
2008 3
2009 8
2010 4
2011 10
2012 7
2013 13
2014 14
2015 22
2016 24
2017 25
2018 28
2019 25
2020 19
2021 19
2022 28
2023 10
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

216 results

Results by year

Filters applied: . Clear all
Page 1
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.
Howes OD, McCutcheon R, Agid O, de Bartolomeis A, van Beveren NJ, Birnbaum ML, Bloomfield MA, Bressan RA, Buchanan RW, Carpenter WT, Castle DJ, Citrome L, Daskalakis ZJ, Davidson M, Drake RJ, Dursun S, Ebdrup BH, Elkis H, Falkai P, Fleischacker WW, Gadelha A, Gaughran F, Glenthøj BY, Graff-Guerrero A, Hallak JE, Honer WG, Kennedy J, Kinon BJ, Lawrie SM, Lee J, Leweke FM, MacCabe JH, McNabb CB, Meltzer H, Möller HJ, Nakajima S, Pantelis C, Reis Marques T, Remington G, Rossell SL, Russell BR, Siu CO, Suzuki T, Sommer IE, Taylor D, Thomas N, Üçok A, Umbricht D, Walters JT, Kane J, Correll CU. Howes OD, et al. Among authors: graff guerrero a. Am J Psychiatry. 2017 Mar 1;174(3):216-229. doi: 10.1176/appi.ajp.2016.16050503. Epub 2016 Dec 6. Am J Psychiatry. 2017. PMID: 27919182 Free PMC article. Review.
Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment.
Wada M, Noda Y, Iwata Y, Tsugawa S, Yoshida K, Tani H, Hirano Y, Koike S, Sasabayashi D, Katayama H, Plitman E, Ohi K, Ueno F, Caravaggio F, Koizumi T, Gerretsen P, Suzuki T, Uchida H, Müller DJ, Mimura M, Remington G, Grace AA, Graff-Guerrero A, Nakajima S. Wada M, et al. Among authors: graff guerrero a. Mol Psychiatry. 2022 Jul;27(7):2950-2967. doi: 10.1038/s41380-022-01572-0. Epub 2022 Apr 20. Mol Psychiatry. 2022. PMID: 35444257 Review.
Insight and medication adherence in schizophrenia: An analysis of the CATIE trial.
Kim J, Ozzoude M, Nakajima S, Shah P, Caravaggio F, Iwata Y, De Luca V, Graff-Guerrero A, Gerretsen P. Kim J, et al. Among authors: graff guerrero a. Neuropharmacology. 2020 May 15;168:107634. doi: 10.1016/j.neuropharm.2019.05.011. Epub 2019 May 9. Neuropharmacology. 2020. PMID: 31077729 Clinical Trial.
COVID-19 behavior determinants dataset.
Song J, Kim J, Graff-Guerrero A, Quilty L, Sanches M, Wells S, Brown EE, Agic B, Pollock BG, Gerretsen P. Song J, et al. Among authors: graff guerrero a. Data Brief. 2022 Dec;45:108732. doi: 10.1016/j.dib.2022.108732. Epub 2022 Nov 8. Data Brief. 2022. PMID: 36407792 Free PMC article.
Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies.
Nakahara T, Tsugawa S, Noda Y, Ueno F, Honda S, Kinjo M, Segawa H, Hondo N, Mori Y, Watanabe H, Nakahara K, Yoshida K, Wada M, Tarumi R, Iwata Y, Plitman E, Moriguchi S, de la Fuente-Sandoval C, Uchida H, Mimura M, Graff-Guerrero A, Nakajima S. Nakahara T, et al. Among authors: graff guerrero a. Mol Psychiatry. 2022 Jan;27(1):744-757. doi: 10.1038/s41380-021-01297-6. Epub 2021 Sep 28. Mol Psychiatry. 2022. PMID: 34584230 Review.
Psychosis in frontotemporal dementia.
Shinagawa S, Nakajima S, Plitman E, Graff-Guerrero A, Mimura M, Nakayama K, Miller BL. Shinagawa S, et al. Among authors: graff guerrero a. J Alzheimers Dis. 2014;42(2):485-99. doi: 10.3233/JAD-140312. J Alzheimers Dis. 2014. PMID: 24898651 Review.
Brain insulin action in schizophrenia: Something borrowed and something new.
Agarwal SM, Caravaggio F, Costa-Dookhan KA, Castellani L, Kowalchuk C, Asgariroozbehani R, Graff-Guerrero A, Hahn M. Agarwal SM, et al. Among authors: graff guerrero a. Neuropharmacology. 2020 Feb;163:107633. doi: 10.1016/j.neuropharm.2019.05.010. Epub 2019 May 8. Neuropharmacology. 2020. PMID: 31077731 Review.
Determinants of social distancing adherence.
Gerretsen P, Kim J, Brown EE, Quilty LC, Wells S, Caravaggio F, Song J, Sanches M, Agic B, Pollock BG, Graff-Guerrero A. Gerretsen P, et al. Among authors: graff guerrero a. Front Public Health. 2023 Jan 12;10:977857. doi: 10.3389/fpubh.2022.977857. eCollection 2022. Front Public Health. 2023. PMID: 36711412 Free PMC article.
Glutamate-mediated excitotoxicity in schizophrenia: a review.
Plitman E, Nakajima S, de la Fuente-Sandoval C, Gerretsen P, Chakravarty MM, Kobylianskii J, Chung JK, Caravaggio F, Iwata Y, Remington G, Graff-Guerrero A. Plitman E, et al. Among authors: graff guerrero a. Eur Neuropsychopharmacol. 2014 Oct;24(10):1591-605. doi: 10.1016/j.euroneuro.2014.07.015. Epub 2014 Aug 1. Eur Neuropsychopharmacol. 2014. PMID: 25159198 Free PMC article. Review.
216 results